Table 3.
Timeline for the emergence of pathophysiological and behavioral hallmarks in various animal models of AD
S.No. | Animal model | Timeline for Pathophysiological alterations | Timeline for behavioral alterations | References |
---|---|---|---|---|
1. | Streptozotocin | 21 days | 15 days | [20, 21, 136, 137] |
2. | Scopolamine | 13 days | 9 days | [35, 36] |
3. | Colchicine | 2 weeks | 21 days | [138, 139] |
4. | Okadaic acid | 13 days | 10 days | [140, 141] |
5. | Amyloid-β1-42 | 15 days | 14 days | [142, 143] |
6. | Acrolein | 12 weeks | 4 weeks | [144, 145] |
7. | Heavy metals | 25 days | 21 days | [146, 147] |
8. | PDAPP | 6–9 months | 3–4 months | [148, 149] |
9. | APP23 | 6 months | 3 months | [150, 151] |
10. | Tg2576 | 3 months | 9–10 months | [88, 148] |
11. | hAPP-J20 | 5–6 months | 9–12 months | [96, 97] |
12. | P301S mice | 6 months | 9–12 months | [101] |
13. | APP/PS1 | 2–3 months | 120–250 days | [148] |
14. | 3 × Tg | 6–12 months | 4 months | [108, 109] |
15. | 5 × FAD | 2 months old | 4–5 months | [152] |